Symbol
LCTX on NYSE
Investment type
Equity / Common shares
Latest Disclosed Ownership
57.8M shares
Security Ownership
23.1%

NEAL C. BRADSHER ownership in Lineage Cell Therapeutics, Inc. Common shares (LCTX)

2025-11-14 - NEAL C. BRADSHER has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 57.8M shares of Lineage Cell Therapeutics, Inc. Common shares (LCTX). This represents 23.1% percent ownership of the company.